FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892558084> ?p ?o ?g. }

• W2892558084 abstract "Background: Several mechanisms have been suggested to explain the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and its progression, one of which is increased oxidative stress. Objectives: This study aimed to evaluate the effect of alpha-lipoic acid (ALA) supplementation on anthropometric indices, dietary intake and oxidative stress-related parameters in obese patients with NAFLD. Methods: In this double-blind, placebo-controlled trial, 50 NAFLD patients were assigned to two groups of receiving 1200 mg ALA (two 600 mg capsules of ALA) and placebo (two 600 mg capsules of placebo) for 12 weeks. Serum liver enzymes, malondialdehyde (MDA) level, total antioxidant status (TAS), and the activities of copper-zinc superoxide dismutase (Cu/Zn-SOD) and glutathione peroxidase (GSH-Px) were assessed at baseline and after 12 weeks of intervention. Results: Serum concentrations of liver enzymes decreased significantly in the ALA group (P < 0.05 for all), while a noticeable decline was observed for alanine aminotransferase (ALT) in the placebo group (32.5 ± 18.9 vs. 25.9 ± 11.2; P = 0.034). Nonetheless, there were no significant differences between the study groups concerning serum liver enzymes concentrations post-intervention. Although ALA supplementation significantly reduced the serum concentration of MDA (2.52 ± 0.35 vs. 2.77 ± 0.49; P < 0.040) and increased serum TAS (1.73 ± 0.55 vs. 1.52 ± 0.34; P < 0.048), other oxidative stress-related parameters such as Cu/Zn-SOD and GSH-Px activities were not affected. Conclusions: These findings suggest that daily supplementation of 1200 mg alpha-lipoic acid (ALA) for 12 weeks improves oxidative stress markers in patients with nonalcoholic fatty liver disease (NAFLD) and it could be considered as adjunctive therapy for the prevention of NAFLD progression." @default.
• W2892558084 created "2018-10-05" @default.
• W2892558084 creator A5008084304 @default.
• W2892558084 creator A5009174271 @default.
• W2892558084 creator A5010412774 @default.
• W2892558084 creator A5085489372 @default.
• W2892558084 creator A5089537656 @default.
• W2892558084 date "2018-09-25" @default.
• W2892558084 modified "2023-10-18" @default.
• W2892558084 title "Effects of Alpha-Lipoic Acid Supplementation on Oxidative Stress Status in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double Blind, Placebo-Controlled Clinical Trial" @default.
• W2892558084 cites W1576683498 @default.
• W2892558084 cites W1583462726 @default.
• W2892558084 cites W1768677346 @default.
• W2892558084 cites W1834204574 @default.
• W2892558084 cites W1966553114 @default.
• W2892558084 cites W1974052747 @default.
• W2892558084 cites W1977681189 @default.
• W2892558084 cites W1977724267 @default.
• W2892558084 cites W1999403141 @default.
• W2892558084 cites W2000540842 @default.
• W2892558084 cites W2002349285 @default.
• W2892558084 cites W2004177180 @default.
• W2892558084 cites W2021568039 @default.
• W2892558084 cites W2028043291 @default.
• W2892558084 cites W2029708291 @default.
• W2892558084 cites W2034298464 @default.
• W2892558084 cites W2039422087 @default.
• W2892558084 cites W2039678693 @default.
• W2892558084 cites W2041654142 @default.
• W2892558084 cites W2045155139 @default.
• W2892558084 cites W2048685833 @default.
• W2892558084 cites W2052701666 @default.
• W2892558084 cites W2053054955 @default.
• W2892558084 cites W2054086826 @default.
• W2892558084 cites W2058933166 @default.
• W2892558084 cites W2059405647 @default.
• W2892558084 cites W2062654788 @default.
• W2892558084 cites W2078600320 @default.
• W2892558084 cites W2098666438 @default.
• W2892558084 cites W2099851474 @default.
• W2892558084 cites W2114952735 @default.
• W2892558084 cites W2121560836 @default.
• W2892558084 cites W2135723126 @default.
• W2892558084 cites W2151641001 @default.
• W2892558084 cites W2152045883 @default.
• W2892558084 cites W2153040341 @default.
• W2892558084 cites W2156813826 @default.
• W2892558084 cites W2172157712 @default.
• W2892558084 cites W2175479903 @default.
• W2892558084 cites W2246949337 @default.
• W2892558084 cites W2657296316 @default.
• W2892558084 cites W2750832778 @default.
• W2892558084 cites W2759997926 @default.
• W2892558084 cites W4235609024 @default.
• W2892558084 doi "https://doi.org/10.5812/ircmj.67615" @default.
• W2892558084 hasPublicationYear "2018" @default.
• W2892558084 type Work @default.
• W2892558084 sameAs 2892558084 @default.
• W2892558084 citedByCount "7" @default.
• W2892558084 countsByYear W28925580842019 @default.
• W2892558084 countsByYear W28925580842020 @default.
• W2892558084 countsByYear W28925580842021 @default.
• W2892558084 countsByYear W28925580842022 @default.
• W2892558084 crossrefType "journal-article" @default.
• W2892558084 hasAuthorship W2892558084A5008084304 @default.
• W2892558084 hasAuthorship W2892558084A5009174271 @default.
• W2892558084 hasAuthorship W2892558084A5010412774 @default.
• W2892558084 hasAuthorship W2892558084A5085489372 @default.
• W2892558084 hasAuthorship W2892558084A5089537656 @default.
• W2892558084 hasBestOaLocation W28925580841 @default.
• W2892558084 hasConcept C126322002 @default.
• W2892558084 hasConcept C141071460 @default.
• W2892558084 hasConcept C142724271 @default.
• W2892558084 hasConcept C168563851 @default.
• W2892558084 hasConcept C204787440 @default.
• W2892558084 hasConcept C27081682 @default.
• W2892558084 hasConcept C2775944032 @default.
• W2892558084 hasConcept C2776151105 @default.
• W2892558084 hasConcept C2778772119 @default.
• W2892558084 hasConcept C2779134260 @default.
• W2892558084 hasConcept C2779965577 @default.
• W2892558084 hasConcept C2910140794 @default.
• W2892558084 hasConcept C2991744798 @default.
• W2892558084 hasConcept C49453240 @default.
• W2892558084 hasConcept C535046627 @default.
• W2892558084 hasConcept C64943373 @default.
• W2892558084 hasConcept C71924100 @default.
• W2892558084 hasConcept C90924648 @default.
• W2892558084 hasConceptScore W2892558084C126322002 @default.
• W2892558084 hasConceptScore W2892558084C141071460 @default.
• W2892558084 hasConceptScore W2892558084C142724271 @default.
• W2892558084 hasConceptScore W2892558084C168563851 @default.
• W2892558084 hasConceptScore W2892558084C204787440 @default.
• W2892558084 hasConceptScore W2892558084C27081682 @default.
• W2892558084 hasConceptScore W2892558084C2775944032 @default.
• W2892558084 hasConceptScore W2892558084C2776151105 @default.
• W2892558084 hasConceptScore W2892558084C2778772119 @default.
• W2892558084 hasConceptScore W2892558084C2779134260 @default.
• W2892558084 hasConceptScore W2892558084C2779965577 @default.
• W2892558084 hasConceptScore W2892558084C2910140794 @default.

• next